Product Description
Albumin bound Paclitaxel is a novel nanoparticle formulation of paclitaxel using human albumin as carrier. It avoids traditional solvent-related hypersensitivity reactions, enhances tumor tissue targeting and drug enrichment. It inhibits tumor cell mitosis, blocks cell proliferation, induces cancer cell apoptosis, with higher efficacy and better safety tolerance than conventional paclitaxel injection.
Indications
- Metastatic breast cancer
- Non-small cell lung cancer
- Ovarian cancer, pancreatic cancer
- Other advanced solid tumors as first-line or combined chemotherapy
- Adjuvant chemotherapy for malignant tumor postoperative treatment
Administration
Reconstitute strictly per standard procedure, administer by intravenous infusion only. Dosage based on body surface area, tumor type and patient physical condition. Must be prepared and used by professional oncology medical staff under close clinical monitoring.
Product Features
- Standard spec: 100mg / 20mL vial
- Albumin nanoparticle targeted delivery
- No need for pre-medication anti-allergy routine
- Higher tumor targeting, stronger anti-tumor activity
- Lower adverse reaction rate, better patient tolerance
- Stable lyophilized preparation, convenient clinical dispensing
Storage
Store at controlled low temperature, sealed and protected from light; avoid freezing, high temperature and strong light exposure.
Warnings
- Strictly prescription-only anti-tumor chemotherapy drug, used only in professional oncology department.
- Contraindicated in severe hypersensitivity to paclitaxel, albumin or any excipients.
- May cause myelosuppression, alopecia, gastrointestinal reaction and peripheral neuropathy; monitor blood routine and vital signs regularly.
- Contraindicated during pregnancy and lactation.
- Professional protective operation required during preparation; avoid direct contact with skin and mucosa.
- Keep far away from children.
